Michigan Medicine
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT05096260
This study entitled Community-Centered Interventions for Improved Vaccine Uptake for COVID-19 (CIVIC): Getting to Yes, Michigan!, is designed to increase vaccine uptake among populations that experience COVID-19 related disparities. The investigators will focus on the four counties within Michigan where a disproportionate burden of COVID-19 is within African Americans and Latinx communities, i.e., Wayne, Genesee, Kent and Washtenaw Counties. Using a community-based participatory research (CBPR) approach, CIVIC will leverage: its long term relationships with the communities involved, an established CBPR Steering Committee developed and the knowledge gained as a Community Engagement Alliance (CEAL) grant recipient, the resources and networks of the University of Michigan CTSA (MICHR), and the expertise of our academic partners to identify and understand factors that contribute to COVID-19 vaccine hesitancy in African Americans and Latinx communities in Michigan. The investigators will develop and test interventions based on community-centered approaches to achieve a primary goal of increased vaccine uptake.
The investigators will achieve this goal with the following aims:
1. Increase understanding of the barriers and drivers of vaccine uptake and hesitancy; 2. Increase vaccine uptake and decrease vaccine hesitancy through the implementation and evaluation of a multi-component intervention; and maintain, enhance, and evaluate the effectiveness of the CIVIC partnership to equitably engage all partners.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Like many states across the country, COVID-19 cases and deaths have impacted communities of color in Michigan at disproportionately higher rates than whites. A staggering reality is that while African Americans represent only 13.6% of Michigan's population, they represent 40% of the deaths from COVID-19.
Preliminary data from the state reveal that these disparities will likely worsen due to significant hesitancy, fear, mistrust and misinformation regarding the COVID-19 vaccine if nothing is done to change current trends.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Eligibility inclusion criteria:
Exclusion criteria
No specific racial, ethnic, nor sex/gender group is excluded.
Our primary framework that will guide the web content is Self-Determination Theory (SDT). SDT differentiates between autonomous (conscious choice and are personally relevant) and controlled behavioral regulation (performed due to pressure or coercion by external or internal forces). Messages that enhance autonomy and perceived competence and are consistent with a person's values and goals will be more effective in changing behavior than messages focusing on external rewards. To link vaccination to broader values and goals, participants will select 3-4 goals from approximately 20 values/goals. Individually tailored messages will link each of these values to vaccination. We will also tailor testimonials based on member values and communication style preference.
Time frame: 6 months after the start of the intervention
The primary outcome is the binary variable of participant-reported vaccine uptake.
Time frame: 6 months
Intention to vaccinate was assessed with a single item, 'How are you currently feeling about getting the updated COVID-19 vaccine? Would you…' with the following response options: 1. Definitely get it, 2. Probably get it, 3. Probably not get it, and 4. Definitely not get it. Responses 1 and 2 were collapsed into 'High intention to vaccinate' and responses 3 and 4 were collapsed into 'Low intention to vaccinate'. The data table shows the number of participants with high intention to vaccinate. Please note we only report this outcome for those NOT reporting vaccination at 6 months
University of Michigan
Other
Community-Centered Interventions for Improved Vaccine Uptake for COVID-19 (CIVIC): Getting to Yes, Michigan! (G2YMI)
Acronym: G2YMI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05012943
COVID-19, COVID-19 Vaccines
Hanoi, Vietnam
View Trial DetailsNCT06199934
COVID-19, COVID-19 Vaccines
New York, United States
View Trial DetailsNCT06989307
Antibodies, Viral, COVID-19
Saint-Denis, France
View Trial DetailsNCT05386355
Behavior, COVID-19
Little Rock, Arkansas, United States
View Trial Details